Delivery Order SPE2DB24D2213-SPE2DB25FGXTT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,879.12 to AmerisourceBergen Drug Corp for Annovera vaginal rings on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded contract represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $4,323.44 to AmerisourceBergen Drug Corp for Annovera vaginal rings on March 11, 2025. This non-competitive, firm fixed-price delivery order is being fulfilled from the company's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of March 12, 2025. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's medical supply chain....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Annovera vaginal rings, valued at $8,469.84 under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 10, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,506.26 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. This competitive award, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency has awarded a delivery order valued at $2,387.01 to AmerisourceBergen Drug Corp for Annovera vaginal rings. This is a firm fixed-price, competitively awarded contract with a completion date of September 23, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $2,954.22 to AmerisourceBergen Drug Corp for Annovera vaginal rings on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed-price, non-set-aside delivery order is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $3,637.53 to AmerisourceBergen Drug Corp for Annovera vaginal rings on July 25, 2025, with completion expected by July 28, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $3,715.03 to AmerisourceBergen Drug Corp for Annovera vaginal rings under a firm fixed-price contract. This non-set-aside award was issued on September 25, 2025, with an ultimate completion date of September 26, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,012.52 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. This competitively awarded contract, with no set-aside designation, was executed on June 25, 2025, with an ultimate completion date of June 26, 2025, and reflects a firm fixed price arrangement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $4,754.04 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. This contract, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. As a competitively awarded delivery order, this contract demonstrates...
- SPE2DB24D2213Indefinite Delivery Contract
- SPE2DB24D2213-SPE2DB25FGXTTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,375.23 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. The contract, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA has structured its pharmaceutical procurement strategy to establish multiple regional contracts under the Pharmaceutical Prime Vendor Global Program Generation V, allowing AmerisourceBergen Drug Corp to serve customers including the Defense Health Agency and U.S. Coast Guard through this flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/5/25 |